HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.

Abstract
We introduced a novel humanized HLA-A*0201 transgenic (HLA Tg) rabbit model to assess the protective efficacy of a human CD8(+) T cell epitope-based vaccine against primary ocular herpes infection and disease. Each of the three immunodominant human CD8(+) T cell peptide epitopes from HSV-1 glycoprotein D (gD(53-61), gD(70-78), and gD(278-286)) were joined with a promiscuous human CD4(+) T cell peptide epitope (gD(49-82)) to construct three separate pairs of CD4-CD8 peptides. Each CD4-CD8 peptide pair was then covalently linked to an N(epsilon)-palmitoyl-lysine residue via a functional base lysine amino group to construct CD4-CD8 lipopeptides. HLA Tg rabbits were immunized s.c. with a mixture of the three CD4-CD8 HSV-1 gD lipopeptides. The HSV-gD-specific T cell responses induced by the mixture of CD4-CD8 lipopeptide vaccine and the protective efficacy against acute virus replication and ocular disease were determined. Immunization induced HSV-gD(49-82)-specific CD4(+) T cells in draining lymph node (DLN); induced HLA-restricted HSV-gD(53-61), gD(70-78), and gD(278-286)-specific CD8(+) T cells in DLN, conjunctiva, and trigeminal ganglia and reduced HSV-1 replication in tears and corneal eye disease after ocular HSV-1 challenge. In addition, the HSV-1 epitope-specific CD8(+) T cells induced in DLNs, conjunctiva, and the trigeminal ganglia were inversely proportional with corneal disease. The humanized HLA Tg rabbits appeared to be a useful preclinical animal model for investigating the immunogenicity and protective efficacy of human CD8(+) T cell epitope-based prophylactic vaccines against ocular herpes. The relevance of HLA Tg rabbits for future investigation of human CD4-CD8 epitope-based therapeutic vaccines against recurrent HSV-1 is discussed.
AuthorsAziz A Chentoufi, Gargi Dasgupta, Neil D Christensen, Jiafen Hu, Zareen S Choudhury, Arfan Azeem, James V Jester, Anthony B Nesburn, Steven L Wechsler, Lbachir BenMohamed
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 184 Issue 5 Pg. 2561-71 (Mar 01 2010) ISSN: 1550-6606 [Electronic] United States
PMID20124097 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Epitopes, T-Lymphocyte
  • HLA-A Antigens
  • HLA-A*02:01 antigen
  • HLA-A2 Antigen
  • Herpes Simplex Virus Vaccines
  • N(epsilon)-palmitoyllysine
  • Peptide Fragments
  • Viral Envelope Proteins
  • glycoprotein D, Human herpesvirus 1
  • Lysine
Topics
  • Amino Acid Sequence
  • Animals
  • Animals, Genetically Modified
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Conjunctiva (immunology, metabolism, virology)
  • Cornea (immunology, metabolism, virology)
  • Epitopes, T-Lymphocyte (chemistry, genetics, immunology)
  • HLA-A Antigens (genetics, immunology)
  • HLA-A2 Antigen
  • Herpes Simplex Virus Vaccines (administration & dosage, genetics, immunology)
  • Herpesvirus 1, Human (immunology)
  • Humans
  • Immunization
  • Keratitis, Herpetic (immunology, prevention & control, virology)
  • Lymph Nodes (immunology, metabolism, virology)
  • Lysine (analogs & derivatives, chemistry)
  • Molecular Sequence Data
  • Peptide Fragments (chemistry, genetics, immunology)
  • Rabbits
  • Trigeminal Ganglion (immunology, metabolism, virology)
  • Viral Envelope Proteins (chemistry, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: